Lexaria Bioscience
Price & Volume
Stats
See more52W Range | $0.46-$1.55 |
Market Cap | $15.2M |
Shares Short | 360,450 |
Financials
See moreRevenue (12 Mos) | $368,000 |
Revenue Growth (YoY) | -88.5% |
Gross Profit (12 Mos) | $368,000 |
Diluted EPS | -$0.49 |
News
See moreYahoo Finance • 16 days ago
Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule
Yahoo Finance • last month
Lexaria's Animal Study Examining Next-Generation GLP-1 drugs is Underway
Yahoo Finance • 2 months ago
Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #7
Yahoo Finance • 2 months ago
Lexaria Updates Progress on Human Study #7
About
CEO | Mr. Richard C. Christopher |
Address | 740 McCurdy Road, Kelowna, BC, Canada, V1X 2P7 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 7 |